BUY Indus Towers — Deven Mehata, IDBI Capital Markets and Securities
byDeven Mehata, IDBI Capital Markets and SecuritiesHorizon: Swing (≤2wk)16 Nov 2026via NDTV Profit (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·16 Nov · today
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·13 Nov · 2d ago
Frog Innovations Ltd receives LOI from Indus Towers Ltd
NewsGoogle News·6 Nov · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Indus Towers
- BUY — Manas Jaiswal13 Nov 2026 · ~2 weeks · target ₹415 · Active
- BUY — IDBI Capital13 Nov 2026 · ~2 weeks · target ₹428 · Active
- BUY — Rakesh Bansal12 Nov 2026 · ~2 weeks · target ₹410 · SL hit
- BUY — Gaurav Sharma, Globe Capital Market12 Nov 2026 · ~2 weeks · target ₹415 · SL hit
- BUY — Ashish Bahety, Profitmart Securities11 Nov 2026 · Same day · target ₹396 · Target hit
More from Deven Mehata, IDBI Capital Markets and Securities
- BUY Balmer Lawrie & Company11 Nov 2026 · ~2 weeks · target ₹200 · Active
- BUY Waaree Energies11 Nov 2026 · ~2 weeks · target ₹2,750 · Active
- BUY Central Depository Services (India)9 Nov 2026 · ~2 weeks · target ₹1,420 · Target hit
- BUY Alkem Laboratories9 Nov 2026 · ~2 weeks · target ₹5,730 · Active
- BUY Onesource Specialty Pharma9 Nov 2026 · ~2 weeks · target ₹1,765 · Active

